BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 16951028)

  • 1. The use of systemic fluoroquinolones.
    Committee on Infectious Diseases
    Pediatrics; 2006 Sep; 118(3):1287-92. PubMed ID: 16951028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Fluoroquinolones in children].
    Gendrel D
    Med Trop (Mars); 2002; 62(2):185-92. PubMed ID: 12192718
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Arrhythmias associated with fluoroquinolone therapy.
    Falagas ME; Rafailidis PI; Rosmarakis ES
    Int J Antimicrob Agents; 2007 Apr; 29(4):374-9. PubMed ID: 17241772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolone antibiotics in infants and children.
    Schaad UB
    Infect Dis Clin North Am; 2005 Sep; 19(3):617-28. PubMed ID: 16102652
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antimicrobial safety: focus on fluoroquinolones.
    Owens RC; Ambrose PG
    Clin Infect Dis; 2005 Jul; 41 Suppl 2():S144-57. PubMed ID: 15942881
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety concerns with fluoroquinolones.
    Mehlhorn AJ; Brown DA
    Ann Pharmacother; 2007 Nov; 41(11):1859-66. PubMed ID: 17911203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The safety profile of moxifloxacin and other fluoroquinolones in special patient populations.
    Iannini PB
    Curr Med Res Opin; 2007 Jun; 23(6):1403-13. PubMed ID: 17559736
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of systemic and topical fluoroquinolones.
    Bradley JS; Jackson MA; ;
    Pediatrics; 2011 Oct; 128(4):e1034-45. PubMed ID: 21949152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric urinary tract infections: the role of fluoroquinolones.
    Koyle MA; Barqawi A; Wild J; Passamaneck M; Furness PD
    Pediatr Infect Dis J; 2003 Dec; 22(12):1133-7. PubMed ID: 14688587
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of hospital formularies on fluoroquinolone prescribing in emergency departments.
    Aspinall SL; Metlay JP; Maselli JH; Gonzales R
    Am J Manag Care; 2007 May; 13(5):241-8. PubMed ID: 17488189
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Quinolone resistance in Gram negative rods in Iceland and association with antibiotic use].
    Jónsdóttir K; Kristinsson KG
    Laeknabladid; 2008 Apr; 94(4):279-85. PubMed ID: 18460726
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety profile of quinolone antibiotics in the pediatric population.
    Grady R
    Pediatr Infect Dis J; 2003 Dec; 22(12):1128-32. PubMed ID: 14688586
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fluoroquinolones in children: poorly defined risk of joint damage.
    Prescrire Int; 2004 Oct; 13(73):184-6. PubMed ID: 15499700
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association between fluoroquinolone usage and a dramatic rise in ciprofloxacin-resistant Streptococcus pneumoniae in Canada, 1997-2006.
    Adam HJ; Hoban DJ; Gin AS; Zhanel GG
    Int J Antimicrob Agents; 2009 Jul; 34(1):82-5. PubMed ID: 19342204
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TARGETed surveillance: susceptibility of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections in 2003 to fluoroquinolones and other agents.
    Morrissey I; Colclough A; Northwood J
    Int J Antimicrob Agents; 2007 Oct; 30(4):345-51. PubMed ID: 17643269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. National trends in emergency department antibiotic prescribing for elders with urinary tract infection, 1996-2005.
    Caterino JM; Weed SG; Espinola JA; Camargo CA
    Acad Emerg Med; 2009 Jun; 16(6):500-7. PubMed ID: 19245373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The Use of Systemic and Topical Fluoroquinolones.
    Jackson MA; Schutze GE;
    Pediatrics; 2016 Nov; 138(5):. PubMed ID: 27940800
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Empiric treatment of uncomplicated urinary tract infection with fluoroquinolones in older women in Israel: another lost treatment option?
    Kahan NR; Chinitz DP; Waitman DA; Dushnitzky D; Kahan E; Shapiro M
    Ann Pharmacother; 2006 Dec; 40(12):2223-7. PubMed ID: 17105833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diplopia and fluoroquinolones.
    Fraunfelder FW; Fraunfelder FT
    Ophthalmology; 2009 Sep; 116(9):1814-7. PubMed ID: 19643481
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Appropriate use of fluoroquinolones in children.
    Principi N; Esposito S
    Int J Antimicrob Agents; 2015 Apr; 45(4):341-6. PubMed ID: 25726705
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.